UT Austin Leads $29 Million Alcoholism Treatment Consortium

AlcoholimagesFeb. 3, 2017 — AUSTIN, Texas — The National Institutes of Health has awarded an international consortium seeking better pharmaceutical treatments for alcoholism a five-year grant totaling $29 million. The administrative headquarters and several of the projects will be at The University of Texas at Austin, which will receive $8.5 million of the total.

The Integrative Neuroscience Initiative on Alcoholism-Neuroimmune consortium will use brain gene studies, brain imaging and human laboratory studies to identify and test potential new treatments for alcoholism.

As part of their work with the consortium, Harris and his team mapped the differences in gene expression between an alcoholic’s brain and a nonalcoholic’s brain. In 2014, they found that, as a person becomes dependent on alcohol, thousands of genes in their brains are turned up or down, like a dimmer switch on a lightbulb, compared with the same genes in a healthy person’s brain.

The scientists are now using an innovative technique to find drugs that can, in a sense, turn those switches back to their original settings and, they hope, revert an alcoholic’s brain into a nonalcoholic brain. The work might one day help the millions of people who suffer with the emotional, financial and health consequences of alcoholism.

This entry was posted in Post Categories. Bookmark the permalink.